PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 27 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Veratric acid derived from cauliflower mushroom demonstrated clinical effects on facial wrinkle improvement by attenuating MMP expression [PMID:26914455].
S. crispa powder suppressed body weight and visceral fat gain in ovariectomized mice [PMID:38545380]; lacto-fermented S. crispa ameliorated hepatic steatosis in obese zebrafish [PMID:32466711]; and a synbiotic of beta-glucans and L. fermentum lowered visceral fat mass in estrogen-deficient rats [PMID:29151980].
Crude polysaccharides from S. crispa inhibited the proliferation of human colon cancer cell lines (Caco-2, LS180, and HT-29) [PMID:33419097].
Ethanol extract of S. crispa reduced glutamate-induced cell death and ROS generation in mouse hippocampal HT22 cells [PMID:37755018].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 40583786 (2026) — Cauliflower mushroom (Sparassis): a promising functional food with nutritional and medicinal properties. · Critical reviews in food science and nutrition
- 2.PMID: 35513833 (2022) — Medicinal, nutritional, and nutraceutical potential of Sparassis crispa s. lat.: a review. · IMA fungus
- 3.PMID: 38545380 (2024) — Wood cauliflower mushroom (Sparassis crispa) suppresses the body weight and visceral fat increased by ovariectomy in mice. · Current research in food science
- 4.PMID: 23586068 (2013) — Natural products and biological activity of the pharmacologically active cauliflower mushroom Sparassis crispa. · BioMed research international
- 5.PMID: 33366786 (2020)